Corticosteroids for treating optic neuritis (Q24246536)

Europe PubMed Central

title

Corticosteroids for treating optic neuritis (English)

0 references

1 reference

1 reference

S S Vedula

1

S S

Vedula

1 reference

19 October 2023

S Brodney-Folse

series ordinal

2

author given names

S

author last names

Brodney-Folse

1 reference

19 October 2023

R L Gal

series ordinal

3

author given names

R L

author last names

Gal

1 reference

19 October 2023

R Beck

series ordinal

4

author given names

R

author last names

Beck

1 reference

Cochrane Database of Systematic Reviews

19 October 2023

language of work or name

English

0 references

publication date

2007

0 references

published in

0 references

issue

1

0 references

page(s)

CD001430

0 references

cites work

Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

The natural history of recurrent optic neuritis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Corticosteroids do not prevent optic nerve atrophy following optic neuritis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Optic neuritis: A population-based study in Olrnsted County, Minnesota

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

A trial of corticotrophin gelatin injection in acute optic neuritis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Estimation of visual function after optic neuritis: a comparison of clinical tests

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Treatment of acute optic neuritis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Treatment of retrobulbar neuritis with corticotrophin.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Treatment of acute retrobulbar neuritis with corticotrophin.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001430.PUB2

Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001430.PUB2

Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001430.PUB2

A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001430.PUB2

41st annual meeting of the Japanese Neuro-Ophthalmology Society, Kyoto, Japan, December 12-13, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001430.PUB2

Optic neuritis--diagnosis, treatment and follow up

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Effect of prednisolone on the course of optic neuritis. Results of a double-blind study

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367867

Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis

29 November 2018

1 reference

12 December 2020

[Progress of optic neuritis with and without corticosteroid treatment. Findings in a long-term investigation with static perimetry]

1 reference

12 December 2020

The Aulhorn flicker test: possibilities and limits. Its use in optic neuritis for diagnosis, differential diagnosis, monitoring the course of the disease, and assessing the effect of oral prednisolone

1 reference

12 December 2020

The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial

1 reference

12 December 2020

Optic neuritis and multiple sclerosis

1 reference

12 December 2020

Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)

1 reference

12 December 2020

[Corticosteroids and acute optic nerve neuritis. A therapeutic method requiring further studies]

1 reference

12 December 2020

Treatmenf of optic neuritis by retrobulbar injection of triamcinolone

1 reference

12 December 2020

[Comparative treatment of acute optic neuritis with "boluses" of intravenous methylprednisolone or oral prednisone]

1 reference

12 December 2020

[Treatment of optic neuritis with corticosteroids. Discussion at the 10th Meeting of the International Neuro-ophthalmological Society (Freiburg 5 to 9 June 1994)]

1 reference

12 December 2020

Optic neuritis or multiple sclerosis

1 reference

12 December 2020

The optic neuritis treatment trial: three-year follow-up results

1 reference

12 December 2020

The Tübingen Study on Optic Neuritis Treatment--a prospective, randomized and controlled trial

1 reference

12 December 2020

Deficits in visual function after resolution of optic neuritis

1 reference

12 December 2020

Treatment of optic neuritis with intravenous megadose corticosteroids. A consecutive series

1 reference

12 December 2020

Contrast sensitivity and other vision tests in the optic neuritis treatment trial

1 reference

12 December 2020

The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study

1 reference

12 December 2020

Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials

1 reference

12 December 2020

Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis

1 reference

12 December 2020

Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)

1 reference

12 December 2020

Design, methods, and conduct of the Optic Neuritis Treatment Trial

1 reference

12 December 2020

Optic neuritis treatment trial. One-year follow-up results

1 reference

12 December 2020

A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis

1 reference

12 December 2020

[Treatment of acute optic neuritis with large doses of corticosteroids]

1 reference

12 December 2020

The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial

1 reference

12 December 2020

Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group

1 reference

12 December 2020

Comparison of stimulation therapy with glucocorticoid therapy in optic nerve inflammation

1 reference

12 December 2020

10.1002/14651858.CD001430.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_bcjxz64lpzfxfpqwct44xtloei

0 references

PMC publication ID

4367867

0 references